175 related articles for article (PubMed ID: 35446898)
1. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.
Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A
Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.
Modemann F; Niederwieser C; Weisel K; Bokemeyer C; Fiedler W; Ghandili S
Leuk Lymphoma; 2022 Mar; 63(3):664-671. PubMed ID: 34668809
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
6. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study.
Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z
Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients.
Bird PW; Badhwar V; Kennedy B; Ladani S; Tang JW
J Med Virol; 2021 Jul; 93(7):4585-4591. PubMed ID: 33595119
[TBL] [Abstract][Full Text] [Related]
8. [SARS-COV-2 infection in patients with hematological malignancies and transplants].
Herrera F; Bues F; Rojas R; Temporiti E; Videla C; Dupont J; Bonvehí P
Medicina (B Aires); 2021; 81(3):396-400. PubMed ID: 34137699
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.
Aumann S; Tsubary U; Nachmias B; Ben Yehuda D; Lavie D; Goldschmidt N; Vainstein V; Libster D; Saban R; Shaulov A; Israel S; Avni B; Grisariu S; Bdolah-Amram T; Gatt M; Zimran E
Eur J Haematol; 2023 Jul; 111(1):135-145. PubMed ID: 37096337
[TBL] [Abstract][Full Text] [Related]
10. The outcome of COVID-19 in patients with hematological malignancy.
Yigenoglu TN; Ata N; Altuntas F; Bascı S; Dal MS; Korkmaz S; Namdaroglu S; Basturk A; Hacıbekiroglu T; Dogu MH; Berber İ; Dal K; Erkurt MA; Turgut B; Ulgu MM; Celik O; Imrat E; Birinci S
J Med Virol; 2021 Feb; 93(2):1099-1104. PubMed ID: 32776581
[TBL] [Abstract][Full Text] [Related]
11. Clinical and virological course of SARS-CoV 2 infected patients in a tertiary care hospital in Pakistan.
Hussain A; Satti L; Hanif F; Shoaib M; Ghauri MA; Khan Niazi GA; Khan MN; Sana F; Yunus F
J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S602-S606. PubMed ID: 33754515
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series.
Boeckel GR; Hölscher SD; Bürger C; Jacob T; Krekeler C; Shumilov E; Reicherts C; Bleckmann A; Lenz G; Vollenberg R; Tepasse PR
Curr Oncol; 2022 Mar; 29(4):2312-2325. PubMed ID: 35448162
[TBL] [Abstract][Full Text] [Related]
13. [Salmonella Bacteremia Accompanying COVID-19: The First Salmonella Co-Infection in the World Unrelated to Pakistan].
Ürkmez FY; Atalay T
Mikrobiyol Bul; 2022 Apr; 56(2):357-364. PubMed ID: 35477237
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.
Levy I; Lavi A; Zimran E; Grisariu S; Aumann S; Itchaki G; Berger T; Raanani P; Harel R; Aviv A; Lavi N; Zuckerman T; Shvidel L; Jarchowsky O; Ellis M; Herzog Tzarfati K; Koren-Michowitz M; Sherf Y; Levi I; Sofer O; Shpilberg O; Dally N; Suriu C; Braester A; Ben Barouch S; Leiba M; Goldstein D; Sarid N; Yeganeh S; Halloun J; Mittelman M; Tadmor T
Leuk Lymphoma; 2021 Dec; 62(14):3384-3393. PubMed ID: 34405767
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study.
Silfverberg T; Wahlin B; Carlson K; Cherif H
Ups J Med Sci; 2022; 127():. PubMed ID: 36120088
[TBL] [Abstract][Full Text] [Related]
16. Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave.
Fong D; Mair MJ; Lanthaler F; Alber M; Mitterer M
Int J Cancer; 2022 Feb; 150(3):431-439. PubMed ID: 34610144
[TBL] [Abstract][Full Text] [Related]
17. Early hematological indicators of severe COVID-19 disease in hospitalized patients: Data from a South Asian population.
Sharif F; Khan S; Junaid A; Jahangir S; Saeed M; Ijaz M; Ahmad IN; Kamran S
Int J Lab Hematol; 2021 Oct; 43(5):1237-1242. PubMed ID: 33837662
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
Wood WA; Neuberg DS; Thompson JC; Tallman MS; Sekeres MA; Sehn LH; Anderson KC; Goldberg AD; Pennell NA; Niemeyer CM; Tucker E; Hewitt K; Plovnick RM; Hicks LK
Blood Adv; 2020 Dec; 4(23):5966-5975. PubMed ID: 33278301
[TBL] [Abstract][Full Text] [Related]
19. Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
Kalicińska E; Kuszczak B; Dębski J; Szukalski Ł; Wątek M; Strzała J; Rybka J; Czyż J; Lech-Marańda E; Zaucha J; Wróbel T
Support Care Cancer; 2021 Jan; 29(1):323-330. PubMed ID: 32361829
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies.
Wu Y; Chen W; Li W; Zhao M; Wei Q; Zhang X; Mei H; Wang Y; Hu Y
Leuk Lymphoma; 2020 Dec; 61(14):3440-3450. PubMed ID: 32840399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
